Skip to main content
Webinar: Don’t Let Your PBM Off the Hook Watch our latest webinar "Don’t Let Your PBM Off the Hook!"

The clear choice in pharmacy benefit management.

Insights Archive

Filter by:

pen injectable representing biosimilar medication.

November 3, 2024

Humira® biosimilars in focus

For years, Humira® (adalimumab) has been a significant driver of healthcare costs due to its high price and utilization. With the introduction of several Humira biosimilars, learn how ClearScript has been monitoring the landscape and adapting strategies to provide members access to cost-effective therapy options for better health.